Phoenix Pharmatech Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
15
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$6M
- Investors
-
2
Phoenix Pharmatech General Information
Description
Developer of an advanced pill identification system designed to eliminate human errors in medication dispensing in pharmacies. The company's system determines the medication and dosage of individual pills in real-time and checks each pill in a medication pass against the doctor's prescription, enabling users to take the right medicine with the right dosage every time.
Contact Information
Website
www.phoenixpharmatech.comCorporate Office
- 4610 South 133rd Street
- Suite 101
- Omaha, NE 68137
- United States
Corporate Office
- 4610 South 133rd Street
- Suite 101
- Omaha, NE 68137
- United States
Phoenix Pharmatech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC (Series B) | 23-Jun-2023 | $6M | Completed | Generating Revenue | ||
| 8. Later Stage VC (Series A) | 22-Jul-2021 | Completed | Generating Revenue | |||
| 7. Debt - PPP | 13-Apr-2020 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series C) | 11-Oct-2018 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series B1) | 10-Jul-2016 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series A2) | 25-Mar-2015 | Completed | Generating Revenue | |||
| 3. Grant | Completed | Generating Revenue | ||||
| 2. Early Stage VC (Series A1) | 15-Sep-2013 | $500K | $3.62M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 04-Dec-2012 | $3.12M | $3.12M | Completed | Generating Revenue |
Phoenix Pharmatech Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Phoenix Pharmatech Patents
Phoenix Pharmatech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20210059904-A1 | Pill feeder | Inactive | 30-Aug-2019 | ||
| CA-3064281-A1 | Inventory assurance | Pending | 28-Jun-2017 | ||
| US-20190006037-A1 | Inventory assurance | Inactive | 28-Jun-2017 | ||
| WO-2019006200-A1 | Inventory assurance | Inactive | 28-Jun-2017 | ||
| US-10535425-B2 | Inventory management | Active | 28-Jun-2017 | G16H20/13 |
Phoenix Pharmatech Signals
Phoenix Pharmatech Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CQuence Health | Holding Company | Minority | ||
| New Science Ventures | Venture Capital | Minority |
Phoenix Pharmatech FAQs
-
When was Phoenix Pharmatech founded?
Phoenix Pharmatech was founded in 2011.
-
Where is Phoenix Pharmatech headquartered?
Phoenix Pharmatech is headquartered in Omaha, NE.
-
What is the size of Phoenix Pharmatech?
Phoenix Pharmatech has 15 total employees.
-
What industry is Phoenix Pharmatech in?
Phoenix Pharmatech’s primary industry is Pharmaceuticals.
-
Is Phoenix Pharmatech a private or public company?
Phoenix Pharmatech is a Private company.
-
What is the current valuation of Phoenix Pharmatech?
The current valuation of Phoenix Pharmatech is .
-
What is Phoenix Pharmatech’s current revenue?
The current revenue for Phoenix Pharmatech is .
-
How much funding has Phoenix Pharmatech raised over time?
Phoenix Pharmatech has raised $47.1M.
-
Who are Phoenix Pharmatech’s investors?
CQuence Health and New Science Ventures have invested in Phoenix Pharmatech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process